NYU Langone Health

What NYU Langone Health does

NYU Langone Health is an integrated nonprofit academic medical center affiliated with New York University, delivering patient care, medical education, and biomedical research across a network of seven hospitals and more than 330 outpatient locations spanning Manhattan, Brooklyn, Queens, Long Island, Westchester, Connecticut, New Jersey, and Florida. The system is led by Dean and CEO Alec Kimmelman and CEO Robert I. Grossman, and operates 6,000+ providers supported by an NYU Grossman School of Medicine talent pipeline. Specialty institutes include the nationally #1-ranked NYU Langone Transplant Institute (heart, kidney, liver, lung, pancreas), NYU Langone Heart, Rusk Rehabilitation (top-5 nationally), Hassenfeld Children's Hospital, and Perlmutter Cancer Center.

The underlying technology stack combines Epic electronic health records, MyChart patient portal, and the proprietary Precision Medicine Registry (PMED) capturing longitudinal clinical data on approximately 2 million patients since 2010. NYU Langone has built differentiated AI capabilities including BERT-based patient portal triage, real-time Databricks-powered clinical decision support in emergency rooms, the Sybil lung cancer imaging AI, BI-RADS breast cancer risk assessment research, and a depression-detecting smartphone game. Research infrastructure is reinforced by multi-million-dollar NIH grants supporting the NYU-Sage NAMs Data Hub ($25M), the National Center for Engagement in Diabetes Equity Research ($13M), and a $70M NIH award in May 2026.

The business model is patient care services billed through insurance plans with financial assistance programs, supplemented by NIH and foundation research grants. Distribution is direct-to-patient across hospitals, ambulatory surgery centers, outpatient practices, telemedicine (Virtual Urgent Care), and consumer-facing digital tools (the NYU Langone Health App and AI Assistant). Strategic partnerships with Bracco Imaging, Tempus AI, Smith+Nephew, Inspira Technologies, Sage Bionetworks, and Hera extend capabilities in imaging, molecular profiling, surgical robotics, extracorporeal circulation, data harmonization, and senior care coordination. Recent growth has been driven by aggressive geographic expansion (Long Island, Florida, Brooklyn), tuck-in acquisitions (Rothman Orthopaedic Institute, Pediatric Associates of NYC), and the planned 500-bed Melville academic medical center.

Name

NYU Langone Health

Legal name

NYU Langone Hospitals

Website

https://nyulangone.org

Company type

Private

Founded year

1969

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

NYU Langone Health is a nonprofit academic medical center affiliated with New York University, operating 330+ locations including seven hospitals across the New York metro area and Florida, delivering integrated patient care, research, and medical education with 6,000+ providers.

Ownership category

akta.pro rank

Product category

Academic Healthcare Services

NAICS

General Medical and Surgical Hospitals (6221), Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Specialty (except Psychiatric and Substance Abuse) Hospitals (6223)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062), Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093), Services-Health Services (8000)

akta.pro primary industry

Hospital-Based Emergency Departments (EDs) (HLAFADAA)

Keywords

• Academic medical center
• Hospital care services
• Organ transplantation
• Rehabilitation medicine
• Medical research

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices10 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Patient Care Services: NYU Langone Health operates as an integrated academic medical center generating revenue primarily through patient care services including hospital care, physician services, outpatient clinics, diagnostic services, and surgical procedures across more than 330 locations.

Pricing tiers

Go-to-market motion1 record

Distribution channels6 records

Marketing channels6 records

Core offering

NYU Langone Health is an integrated academic medical center that delivers comprehensive inpatient and outpatient healthcare through seven hospitals and over 330 ambulatory locations across the New York metropolitan area and Florida. Its clinical portfolio spans primary care, specialty care, organ transplantation, cancer care, rehabilitation, and pediatric services, supported by an electronic health record system (Epic/MyChart), an AI-enabled clinical decision support layer, and a Precision Medicine Registry aggregating longitudinal data from approximately 2 million patients.

Product overview

NYU Langone Health is an integrated academic health system organized around three missions: patient care, medical education, and research. The organization operates a network of over 330 locations across the New York region and Florida, including seven hospitals. Its product portfolio centers on direct patient care services organized by specialty (Transplant Institute, NYU Langone Heart, Orthopedics, Hassenfeld Children's Hospital, Rusk Rehabilitation), digital health tools (NYU Langone Health App, MyChart Patient Portal, AI Assistant chatbot), and research infrastructure (Precision Medicine Registry). Strategic partnerships include the Hera Juno AI platform for senior care coordination and the NYU-Sage NAMs Data Hub for biomedical data harmonization.

Differentiator

Problem solved

Functional benefit

Brands

• NYU Langone Transplant Institute: Specializes in heart, kidney, liver, lung, and pancreas transplantation. Performs more transplants than any other hospital in the Northeast.
• NYU Langone Heart
• Perlmutter Cancer Center
• Hassenfeld Children's Hospital
• Rusk Rehabilitation

Products and services

• NYU Langone Transplant Institute Comprehensive transplant center performing heart, kidney, liver, lung, and pancreas transplants for adult and pediatric patients, including living donor programs and xenotransplantation research. Named by SRTR as the nation's premier program for heart, kidney, liver, and lung transplant.
• NYU Langone Heart Cardiology and cardiovascular surgery program ranked as the No. 1 cardiology, heart, and vascular surgery program in the nation by U.S. News & World Report 2025. Delivers diagnostic, interventional, and surgical cardiac care across inpatient and outpatient sites.
• NYU Langone Orthopedics Orthopedic care program for knee, shoulder, hip, and other musculoskeletal conditions, utilizing Smith+Nephew's CORI XT Handheld Robotics Platform for procedures across hospital and ambulatory surgery center environments. Strengthened by the 2025 acquisition of Rothman Orthopaedic Institute.
• Perlmutter Cancer Center Comprehensive cancer center delivering diagnosis, treatment, and clinical trials across solid tumors and hematologic malignancies. Serves as a clinical trial site for partners such as BriaCell Therapeutics' Bria-ABC Phase 3 breast cancer study and integrates Tempus AI for molecular profiling.
• Hassenfeld Children's Hospital at NYU Langone Pediatric hospital providing age-appropriate care including the Stephen D. Hassenfeld Children's Center for Cancer and Blood Disorders and the Division of Pediatric Hematology-Oncology led by Dr. Lisa G. Roth. Supports pediatric oncology, surgery, and transplant services.
• Rusk Rehabilitation Top-5 nationally ranked rehabilitation medicine center serving over 550,000 outpatients and 2,000 inpatients annually across 27 locations with 780 clinicians, providing physical medicine and rehabilitation for stroke recovery, traumatic brain injury, spinal cord injury, and post-surgical recovery.
• NYU Langone Health App Mobile application integrated with Epic MyChart that allows patients to schedule appointments, view test results and clinical notes, message care teams, review medications, request prescription refills, access full electronic health records, manage bill payments, and coordinate care for family members.
• MyChart Patient Portal Secure online patient portal powered by Epic that provides access to medical records, secure messaging with healthcare providers, appointment scheduling, prescription refills, and bill payment for NYU Langone Health patients.
• NYU Langone AI Assistant AI-powered chatbot on the NYU Langone Health website providing conversational assistance for site navigation, information lookup, and patient inquiry routing, building on BERT-based natural-language processing for patient portal triage.
• Virtual Urgent Care Telemedicine service offering video visits with NYU Langone providers for urgent care needs, plus remote patient monitoring for chronic conditions such as hypertension, enabling care delivery without an in-person visit.
• Precision Medicine Registry (PMED) Longitudinal database capturing clinical data from approximately 2 million patients since January 2010, updated quarterly. Supports cohort analyses, risk prediction model validation (KFRE, PREVENT scores), AI-driven imaging analytics including the Sybil lung cancer algorithm, and monitoring of guideline-directed therapy uptake.
• NYU Langone Hospital - Brooklyn Inpatient hospital facility in Brooklyn delivering acute care, emergency services, surgical care, and specialty services integrated with the NYU Langone Health academic network.
• NYU Langone Hospital - Long Island Inpatient hospital facility on Long Island (Nassau County), designated as a Magnet organization by ANCC since 2016 and 2021, providing acute care and specialty services including neonatal continuing care.
• NYU Langone Ambulatory Care - Patchogue 54,000-square-foot ambulatory surgery center in Patchogue, NY featuring six operating rooms that delivers outpatient surgical and specialty care across Suffolk County.
• Depression Detection Smartphone Game Three-minute smartphone game that detects major depressive disorder by tracking persistence patterns in a digital apple-collecting task, measuring anhedonia through anterior cingulate cortex activity.
• PREVENT CVD Risk Prediction Tool Validation Validation study of the American Heart Association's PREVENT cardiovascular disease risk prediction tool across 6.4 million people globally, demonstrating accuracy for worldwide clinical use.
• NYU-Sage NAMs Data Hub and Coordination Center Cloud-based data hub and coordination center for the NIH Complement-ARIE program, using the FUSION framework to standardize and harmonize data from human-based testing methods including 3D cell systems, organoid systems, AI models, and computational toxicology tools.

Quantifiable outcome

• Vizient ranked NYU Langone #1 for quality care in the US for four consecutive years
• +3 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability10 records

Feature4 records

Partnerships

Five partnerships are on record, tiered minor and core.

• BriaCell TherapeuticsminorStrategic or Co-development Partner · 7 May 2026NYU Langone Health's Perlmutter Cancer Center added as a clinical trial site for BriaCell's pivotal Phase 3 breast cancer study (Bria-ABC), evaluating Bria-IMT combined with an immune checkpoint inhibitor in advanced metastatic breast cancer patients. The company's Bria-IMT regimen holds FDA Fast Track designation.
• Bracco ImagingcoreStrategic or Co-development Partner · 20 April 2026Strategic alliance through a multi-year Master Research Agreement to advance medical imaging technologies. Focus areas include MRI, photon-counting CT, targeted ultrasound, and AI-enabled PET/CT and MRI image analysis. The collaboration aims to translate scientific discoveries into real-world healthcare applications and advance precision medicine.
• BioLineRx Ltd.minorStrategic or Co-development Partner · 26 March 2026First-in-human Phase 1/2a clinical trial of GLIX1, an oral TET2 activator for recurrent and progressive glioblastoma and other high-grade gliomas. Trial led by Dr. Roger Stupp at NYU Langone Health along with Northwestern University and Moffitt Cancer Center. Initial Phase 1 data expected H1 2027.
• Hemispherian ASminorStrategic or Co-development Partner · 26 March 2026Norway-based Hemispherian AS collaborated with BioLineRx on development of GLIX1, a first-in-class oral small molecule designed to activate TET2 and induce tumor DNA damage. Glioblastoma selected as initial indication due to suppressed TET2 activity and significant unmet medical need.
• Sage BionetworkscoreStrategic or Co-development Partner · 18 March 2026Partnership with Sage Bionetworks to co-lead the NYU-Sage NAMs Data Hub and Coordination Center for the NIH Complement-ARIE program. The $25 million NIH Common Fund grant over five years will establish a cloud-based platform using FUSION framework to standardize and harmonize data from human-based testing methods including organoid systems, AI models, and computational toxicology tools. Sage hosts the FAIR-compliant data backbone on its Synapse platform.

Scale indicators13 records

Recent moves12 records

Expansion highlights8 records

Direct peers

• Hospital for Special Surgery: Direct orthopedic peer in New York City, ranked #1 in orthopedics by U.S. News. Directly comparable on NYU Langone Orthopedic Hospital and its Smith+Nephew robotics partnership, and competes for high-margin orthopedic surgical volume in the same metro.
• Northwell Health: Direct NY-metro peer — the largest private employer in New York State with a comparable mix of academic tertiary care and a large community/ambulatory footprint. Competes with NYU Langone on Long Island, in Brooklyn, and across the integrated delivery network space.
• NewYork-Presbyterian Hospital: Direct NY-metro academic medical center peer, also affiliated with Columbia and Cornell medical schools. Competes head-to-head with NYU Langone across tertiary and quaternary service lines, transplant, and physician practice network rankings, and has historically traded the Vizient top spot with NYU Langone.
• Mount Sinai Health System: Direct NY-metro academic medical center peer operating multiple hospitals and a large ambulatory footprint across Manhattan, Brooklyn, and Queens. Competes with NYU Langone for tertiary referrals, faculty recruitment, and research funding within the same geography.
• Memorial Sloan Kettering Cancer Center: Direct cancer-care peer in New York City, competing with Perlmutter Cancer Center for oncology research funding, clinical trial placement, and complex cancer cases. Both institutions sit at the top of US cancer care rankings and compete for the same faculty and patient populations.

Broad incumbents

• Penn Medicine (University of Pennsylvania Health System): Broad national AMC peer, a top-10 Vizient performer and major transplant, oncology, and cardiology program. Comparable in scale, research funding, and service-line breadth, and competes for the same national patient and faculty pool.
• Mass General Brigham: Broad national AMC peer, frequently co-ranked #1 or #2 in Vizient and U.S. News. Comparable in research output, specialty depth, and integrated delivery model; competes with NYU Langone for national brand, research funding, and complex case referrals.
• Johns Hopkins Medicine: Broad national AMC peer and historic quality benchmark, with comparable research funding, transplant capabilities, and specialty rankings. Competes with NYU Langone for federal research dollars, top faculty, and complex case referrals from outside the immediate metro.
• Cleveland Clinic: Broad national AMC peer — a multi-state integrated academic health system frequently co-ranked #1 or #2 in Vizient and U.S. News specialty rankings. Comparable in scale, geographic spread, and clinical research profile, and competes with NYU Langone for national brand and complex referral volume.

Emerging players

• Cedars-Sinai Medical Center: West Coast AMC peer with comparable specialty depth (cardiology, gastroenterology, orthopedics) and growing ambulatory footprint. Not a direct geographic competitor but competes with NYU Langone for national rankings, research funding, and the same high-end commercial payer mix.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/nyulangone
• YouTubeyoutube.com/c/NYULangoneHealth
• Facebookfacebook.com/NYULangone
• LinkedInlinkedin.com/company/nyulangonehealth
• Instagraminstagram.com/nyulangone

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries10 records

Funding overview

Funding rounds5 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments3 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NYU Langone Health